nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—pancreatic cancer—pancreatitis	0.782	1	CtDrD
Docetaxel—ABCC2—bile duct—pancreatitis	0.00531	0.106	CbGeAlD
Docetaxel—ABCC2—bile—pancreatitis	0.00408	0.0817	CbGeAlD
Docetaxel—Dermatitis atopic—Propantheline—pancreatitis	0.00319	0.0539	CcSEcCtD
Docetaxel—Sinus tachycardia—Hyoscyamine—pancreatitis	0.003	0.0507	CcSEcCtD
Docetaxel—KIF11—blood—pancreatitis	0.0024	0.048	CbGeAlD
Docetaxel—TUBB6—Ipratropium bromide—Hyoscyamine—pancreatitis	0.00222	1	CbGdCrCtD
Docetaxel—Supraventricular tachycardia—Hyoscyamine—pancreatitis	0.00185	0.0312	CcSEcCtD
Docetaxel—NR1I2—digestive system—pancreatitis	0.00177	0.0355	CbGeAlD
Docetaxel—Haemoglobin decreased—Hyoscyamine—pancreatitis	0.00176	0.0297	CcSEcCtD
Docetaxel—Heartburn—Hyoscyamine—pancreatitis	0.00176	0.0297	CcSEcCtD
Docetaxel—Rash erythematous—Hyoscyamine—pancreatitis	0.00158	0.0267	CcSEcCtD
Docetaxel—MAP2—islet of Langerhans—pancreatitis	0.00152	0.0305	CbGeAlD
Docetaxel—Ageusia—Hyoscyamine—pancreatitis	0.00149	0.0252	CcSEcCtD
Docetaxel—Dysphagia—Propantheline—pancreatitis	0.00148	0.025	CcSEcCtD
Docetaxel—MAP4—pancreas—pancreatitis	0.00136	0.0272	CbGeAlD
Docetaxel—Respiratory failure—Hyoscyamine—pancreatitis	0.00123	0.0208	CcSEcCtD
Docetaxel—Blood pressure increased—Hyoscyamine—pancreatitis	0.00121	0.0204	CcSEcCtD
Docetaxel—Injection site reaction—Hyoscyamine—pancreatitis	0.0012	0.0203	CcSEcCtD
Docetaxel—TUBB3—digestive system—pancreatitis	0.00116	0.0232	CbGeAlD
Docetaxel—MAP4—digestive system—pancreatitis	0.00116	0.0232	CbGeAlD
Docetaxel—Skin exfoliation—Hyoscyamine—pancreatitis	0.00115	0.0195	CcSEcCtD
Docetaxel—TUBB2B—islet of Langerhans—pancreatitis	0.00114	0.0228	CbGeAlD
Docetaxel—MAP4—blood—pancreatitis	0.00111	0.0221	CbGeAlD
Docetaxel—TUBB3—blood—pancreatitis	0.00111	0.0221	CbGeAlD
Docetaxel—Flushing—Propantheline—pancreatitis	0.0011	0.0186	CcSEcCtD
Docetaxel—TUBB1—blood—pancreatitis	0.00108	0.0217	CbGeAlD
Docetaxel—TUBB—islet of Langerhans—pancreatitis	0.00108	0.0216	CbGeAlD
Docetaxel—Pulmonary oedema—Hyoscyamine—pancreatitis	0.00108	0.0182	CcSEcCtD
Docetaxel—TUBB2A—islet of Langerhans—pancreatitis	0.00107	0.0214	CbGeAlD
Docetaxel—MAP2—pancreas—pancreatitis	0.00107	0.0214	CbGeAlD
Docetaxel—TUBB6—islet of Langerhans—pancreatitis	0.00106	0.0211	CbGeAlD
Docetaxel—BCL2—digestive system—pancreatitis	0.00106	0.0211	CbGeAlD
Docetaxel—BCL2—blood—pancreatitis	0.00101	0.0201	CbGeAlD
Docetaxel—Swelling—Hyoscyamine—pancreatitis	0.000995	0.0168	CcSEcCtD
Docetaxel—Atrial fibrillation—Hyoscyamine—pancreatitis	0.000926	0.0156	CcSEcCtD
Docetaxel—TUBB4B—islet of Langerhans—pancreatitis	0.000918	0.0184	CbGeAlD
Docetaxel—MAP2—digestive system—pancreatitis	0.000914	0.0183	CbGeAlD
Docetaxel—Palpitations—Propantheline—pancreatitis	0.000913	0.0154	CcSEcCtD
Docetaxel—Lethargy—Hyoscyamine—pancreatitis	0.000896	0.0151	CcSEcCtD
Docetaxel—Hyponatraemia—Hyoscyamine—pancreatitis	0.000881	0.0149	CcSEcCtD
Docetaxel—MAP2—blood—pancreatitis	0.000871	0.0174	CbGeAlD
Docetaxel—Dry mouth—Propantheline—pancreatitis	0.00086	0.0145	CcSEcCtD
Docetaxel—Confusional state—Propantheline—pancreatitis	0.00085	0.0144	CcSEcCtD
Docetaxel—Anaphylactic shock—Propantheline—pancreatitis	0.000843	0.0142	CcSEcCtD
Docetaxel—TUBB4A—pancreas—pancreatitis	0.000827	0.0166	CbGeAlD
Docetaxel—Ataxia—Hyoscyamine—pancreatitis	0.000825	0.0139	CcSEcCtD
Docetaxel—Tachycardia—Propantheline—pancreatitis	0.000822	0.0139	CcSEcCtD
Docetaxel—Dehydration—Hyoscyamine—pancreatitis	0.000816	0.0138	CcSEcCtD
Docetaxel—Dry skin—Hyoscyamine—pancreatitis	0.000805	0.0136	CcSEcCtD
Docetaxel—TUBB2B—pancreas—pancreatitis	0.0008	0.016	CbGeAlD
Docetaxel—SLC22A7—digestive system—pancreatitis	0.00079	0.0158	CbGeAlD
Docetaxel—Insomnia—Propantheline—pancreatitis	0.000762	0.0129	CcSEcCtD
Docetaxel—Dysphagia—Hyoscyamine—pancreatitis	0.000759	0.0128	CcSEcCtD
Docetaxel—TUBB—pancreas—pancreatitis	0.000757	0.0151	CbGeAlD
Docetaxel—TUBB2A—pancreas—pancreatitis	0.000753	0.0151	CbGeAlD
Docetaxel—Somnolence—Propantheline—pancreatitis	0.000749	0.0127	CcSEcCtD
Docetaxel—TUBB6—pancreas—pancreatitis	0.000742	0.0149	CbGeAlD
Docetaxel—Angina pectoris—Hyoscyamine—pancreatitis	0.000739	0.0125	CcSEcCtD
Docetaxel—Constipation—Propantheline—pancreatitis	0.000721	0.0122	CcSEcCtD
Docetaxel—TUBB4A—digestive system—pancreatitis	0.000707	0.0141	CbGeAlD
Docetaxel—Feeling abnormal—Propantheline—pancreatitis	0.000694	0.0117	CcSEcCtD
Docetaxel—TUBB2B—digestive system—pancreatitis	0.000683	0.0137	CbGeAlD
Docetaxel—TUBB4A—blood—pancreatitis	0.000673	0.0135	CbGeAlD
Docetaxel—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.000667	0.0113	CcSEcCtD
Docetaxel—Myocardial infarction—Hyoscyamine—pancreatitis	0.000663	0.0112	CcSEcCtD
Docetaxel—Conjunctivitis—Hyoscyamine—pancreatitis	0.000657	0.0111	CcSEcCtD
Docetaxel—TUBB4B—pancreas—pancreatitis	0.000645	0.0129	CbGeAlD
Docetaxel—TUBB2A—digestive system—pancreatitis	0.000643	0.0129	CbGeAlD
Docetaxel—TUBB6—digestive system—pancreatitis	0.000634	0.0127	CbGeAlD
Docetaxel—Hypersensitivity—Propantheline—pancreatitis	0.000621	0.0105	CcSEcCtD
Docetaxel—TUBB—blood—pancreatitis	0.000616	0.0123	CbGeAlD
Docetaxel—TUBB2A—blood—pancreatitis	0.000612	0.0123	CbGeAlD
Docetaxel—Asthenia—Propantheline—pancreatitis	0.000605	0.0102	CcSEcCtD
Docetaxel—TUBB6—blood—pancreatitis	0.000604	0.0121	CbGeAlD
Docetaxel—Flushing—Hyoscyamine—pancreatitis	0.000564	0.00952	CcSEcCtD
Docetaxel—Dizziness—Propantheline—pancreatitis	0.000557	0.00941	CcSEcCtD
Docetaxel—ABCC10—digestive system—pancreatitis	0.000555	0.0111	CbGeAlD
Docetaxel—TUBB4B—digestive system—pancreatitis	0.000551	0.011	CbGeAlD
Docetaxel—Arrhythmia—Hyoscyamine—pancreatitis	0.000542	0.00916	CcSEcCtD
Docetaxel—Vomiting—Propantheline—pancreatitis	0.000536	0.00905	CcSEcCtD
Docetaxel—Mental disorder—Hyoscyamine—pancreatitis	0.000532	0.00898	CcSEcCtD
Docetaxel—Rash—Propantheline—pancreatitis	0.000531	0.00897	CcSEcCtD
Docetaxel—Dermatitis—Propantheline—pancreatitis	0.000531	0.00897	CcSEcCtD
Docetaxel—ABCC10—blood—pancreatitis	0.000529	0.0106	CbGeAlD
Docetaxel—Erythema—Hyoscyamine—pancreatitis	0.000529	0.00893	CcSEcCtD
Docetaxel—Headache—Propantheline—pancreatitis	0.000528	0.00892	CcSEcCtD
Docetaxel—TUBB4B—blood—pancreatitis	0.000525	0.0105	CbGeAlD
Docetaxel—Dysgeusia—Hyoscyamine—pancreatitis	0.000518	0.00874	CcSEcCtD
Docetaxel—CYP3A5—islet of Langerhans—pancreatitis	0.000503	0.0101	CbGeAlD
Docetaxel—Nausea—Propantheline—pancreatitis	0.000501	0.00845	CcSEcCtD
Docetaxel—Syncope—Hyoscyamine—pancreatitis	0.000474	0.00801	CcSEcCtD
Docetaxel—Palpitations—Hyoscyamine—pancreatitis	0.000467	0.00789	CcSEcCtD
Docetaxel—Loss of consciousness—Hyoscyamine—pancreatitis	0.000465	0.00785	CcSEcCtD
Docetaxel—Convulsion—Hyoscyamine—pancreatitis	0.000458	0.00773	CcSEcCtD
Docetaxel—Chest pain—Hyoscyamine—pancreatitis	0.00045	0.0076	CcSEcCtD
Docetaxel—ABCC2—digestive system—pancreatitis	0.000446	0.00892	CbGeAlD
Docetaxel—Dry mouth—Hyoscyamine—pancreatitis	0.00044	0.00743	CcSEcCtD
Docetaxel—CYP1B1—digestive system—pancreatitis	0.000437	0.00874	CbGeAlD
Docetaxel—Confusional state—Hyoscyamine—pancreatitis	0.000435	0.00735	CcSEcCtD
Docetaxel—Anaphylactic shock—Hyoscyamine—pancreatitis	0.000431	0.00729	CcSEcCtD
Docetaxel—Oedema—Hyoscyamine—pancreatitis	0.000431	0.00729	CcSEcCtD
Docetaxel—ABCC2—blood—pancreatitis	0.000425	0.0085	CbGeAlD
Docetaxel—Shock—Hyoscyamine—pancreatitis	0.000424	0.00717	CcSEcCtD
Docetaxel—Tachycardia—Hyoscyamine—pancreatitis	0.000421	0.00711	CcSEcCtD
Docetaxel—CYP1B1—blood—pancreatitis	0.000416	0.00833	CbGeAlD
Docetaxel—Hypotension—Hyoscyamine—pancreatitis	0.000403	0.00681	CcSEcCtD
Docetaxel—Insomnia—Hyoscyamine—pancreatitis	0.00039	0.00659	CcSEcCtD
Docetaxel—Dyspnoea—Hyoscyamine—pancreatitis	0.000385	0.0065	CcSEcCtD
Docetaxel—Somnolence—Hyoscyamine—pancreatitis	0.000384	0.00648	CcSEcCtD
Docetaxel—Dyspepsia—Hyoscyamine—pancreatitis	0.00038	0.00641	CcSEcCtD
Docetaxel—ABCC1—blood—pancreatitis	0.000374	0.00749	CbGeAlD
Docetaxel—Fatigue—Hyoscyamine—pancreatitis	0.000372	0.00628	CcSEcCtD
Docetaxel—Constipation—Hyoscyamine—pancreatitis	0.000369	0.00623	CcSEcCtD
Docetaxel—Pain—Hyoscyamine—pancreatitis	0.000369	0.00623	CcSEcCtD
Docetaxel—Feeling abnormal—Hyoscyamine—pancreatitis	0.000356	0.006	CcSEcCtD
Docetaxel—CYP3A5—pancreas—pancreatitis	0.000353	0.00707	CbGeAlD
Docetaxel—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000353	0.00596	CcSEcCtD
Docetaxel—Abdominal pain—Hyoscyamine—pancreatitis	0.000341	0.00576	CcSEcCtD
Docetaxel—Body temperature increased—Hyoscyamine—pancreatitis	0.000341	0.00576	CcSEcCtD
Docetaxel—Hypersensitivity—Hyoscyamine—pancreatitis	0.000318	0.00537	CcSEcCtD
Docetaxel—ABCG2—blood—pancreatitis	0.00031	0.0062	CbGeAlD
Docetaxel—Asthenia—Hyoscyamine—pancreatitis	0.00031	0.00523	CcSEcCtD
Docetaxel—Pruritus—Hyoscyamine—pancreatitis	0.000305	0.00515	CcSEcCtD
Docetaxel—CYP3A5—digestive system—pancreatitis	0.000302	0.00604	CbGeAlD
Docetaxel—Diarrhoea—Hyoscyamine—pancreatitis	0.000295	0.00498	CcSEcCtD
Docetaxel—CYP3A5—blood—pancreatitis	0.000287	0.00576	CbGeAlD
Docetaxel—Dizziness—Hyoscyamine—pancreatitis	0.000285	0.00482	CcSEcCtD
Docetaxel—Vomiting—Hyoscyamine—pancreatitis	0.000274	0.00463	CcSEcCtD
Docetaxel—Rash—Hyoscyamine—pancreatitis	0.000272	0.00459	CcSEcCtD
Docetaxel—Dermatitis—Hyoscyamine—pancreatitis	0.000272	0.00459	CcSEcCtD
Docetaxel—Headache—Hyoscyamine—pancreatitis	0.00027	0.00456	CcSEcCtD
Docetaxel—ABCB1—islet of Langerhans—pancreatitis	0.000267	0.00535	CbGeAlD
Docetaxel—Nausea—Hyoscyamine—pancreatitis	0.000256	0.00433	CcSEcCtD
Docetaxel—CYP3A4—digestive system—pancreatitis	0.000226	0.00453	CbGeAlD
Docetaxel—CYP3A4—blood—pancreatitis	0.000216	0.00432	CbGeAlD
Docetaxel—ABCB1—pancreas—pancreatitis	0.000188	0.00376	CbGeAlD
Docetaxel—ABCB1—digestive system—pancreatitis	0.00016	0.00321	CbGeAlD
Docetaxel—ABCB1—blood—pancreatitis	0.000153	0.00306	CbGeAlD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	1.46e-05	0.000137	CbGpPWpGaD
Docetaxel—BCL2—Immune System—CRP—pancreatitis	1.45e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—pancreatitis	1.45e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—HRAS—pancreatitis	1.45e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—HRAS—pancreatitis	1.45e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CNR1—pancreatitis	1.45e-05	0.000136	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—HRAS—pancreatitis	1.43e-05	0.000135	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—PPARG—pancreatitis	1.42e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—HRAS—pancreatitis	1.42e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Immune System—DUSP6—pancreatitis	1.42e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—HRAS—pancreatitis	1.42e-05	0.000133	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—TLR4—pancreatitis	1.41e-05	0.000132	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—GCG—pancreatitis	1.4e-05	0.000131	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—INS—pancreatitis	1.4e-05	0.000131	CbGpPWpGaD
Docetaxel—BCL2—Immune System—TLR4—pancreatitis	1.39e-05	0.000131	CbGpPWpGaD
Docetaxel—TUBB4B—Metabolism of proteins—CXCL8—pancreatitis	1.39e-05	0.00013	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HLA-DRB1—pancreatitis	1.39e-05	0.00013	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—pancreatitis	1.39e-05	0.00013	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—pancreatitis	1.39e-05	0.00013	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—pancreatitis	1.39e-05	0.00013	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALDH2—pancreatitis	1.38e-05	0.00013	CbGpPWpGaD
Docetaxel—EGFR—Disease—PPP3CA—pancreatitis	1.38e-05	0.000129	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PLA2G1B—pancreatitis	1.38e-05	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—pancreatitis	1.37e-05	0.000129	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—KRAS—pancreatitis	1.37e-05	0.000129	CbGpPWpGaD
Docetaxel—EGFR—Focal Adhesion—HRAS—pancreatitis	1.37e-05	0.000128	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PLA2G1B—pancreatitis	1.37e-05	0.000128	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—pancreatitis	1.36e-05	0.000128	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HLA-DRB1—pancreatitis	1.36e-05	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—pancreatitis	1.36e-05	0.000127	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—NRAS—pancreatitis	1.35e-05	0.000126	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.35e-05	0.000126	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—FDX1—pancreatitis	1.35e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KNG1—pancreatitis	1.34e-05	0.000126	CbGpPWpGaD
Docetaxel—EGFR—B Cell Activation—HRAS—pancreatitis	1.34e-05	0.000126	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALDH2—pancreatitis	1.34e-05	0.000125	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ICAM1—pancreatitis	1.33e-05	0.000125	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR2—pancreatitis	1.33e-05	0.000125	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—A2M—pancreatitis	1.33e-05	0.000125	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—XDH—pancreatitis	1.33e-05	0.000124	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—A2M—pancreatitis	1.32e-05	0.000124	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.3e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—ICAM1—pancreatitis	1.3e-05	0.000122	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—NRAS—pancreatitis	1.3e-05	0.000122	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—pancreatitis	1.28e-05	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SCT—pancreatitis	1.28e-05	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGG—pancreatitis	1.28e-05	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASR—pancreatitis	1.28e-05	0.00012	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CX3CL1—pancreatitis	1.26e-05	0.000118	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	1.25e-05	0.000117	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADH4—pancreatitis	1.25e-05	0.000117	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	1.24e-05	0.000116	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADH1B—pancreatitis	1.24e-05	0.000116	CbGpPWpGaD
Docetaxel—EGFR—Immune System—EGR1—pancreatitis	1.24e-05	0.000116	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—pancreatitis	1.23e-05	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MTNR1B—pancreatitis	1.22e-05	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCK—pancreatitis	1.22e-05	0.000115	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—NRAS—pancreatitis	1.22e-05	0.000114	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALDH2—pancreatitis	1.22e-05	0.000114	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.21e-05	0.000114	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	1.21e-05	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NOD2—pancreatitis	1.21e-05	0.000113	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALDH2—pancreatitis	1.21e-05	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CD14—pancreatitis	1.2e-05	0.000113	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CNR2—pancreatitis	1.19e-05	0.000112	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—A2M—pancreatitis	1.19e-05	0.000112	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TACR1—pancreatitis	1.19e-05	0.000112	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	1.19e-05	0.000111	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PRSS1—pancreatitis	1.18e-05	0.00011	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.17e-05	0.00011	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCKAR—pancreatitis	1.17e-05	0.00011	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—HRAS—pancreatitis	1.17e-05	0.000109	CbGpPWpGaD
Docetaxel—ABCC2—Transmembrane transport of small molecules—ALB—pancreatitis	1.17e-05	0.000109	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—LPL—pancreatitis	1.16e-05	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—KRAS—pancreatitis	1.16e-05	0.000109	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DQA1—pancreatitis	1.16e-05	0.000108	CbGpPWpGaD
Docetaxel—ABCC1—Transmembrane transport of small molecules—ALB—pancreatitis	1.15e-05	0.000108	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PDGFA—pancreatitis	1.13e-05	0.000106	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL5—pancreatitis	1.12e-05	0.000105	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	1.12e-05	0.000105	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—KRAS—pancreatitis	1.12e-05	0.000105	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—pancreatitis	1.12e-05	0.000105	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PNLIP—pancreatitis	1.12e-05	0.000105	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PRSS3—pancreatitis	1.12e-05	0.000105	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PDGFA—pancreatitis	1.1e-05	0.000104	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGA—pancreatitis	1.09e-05	0.000102	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.06e-05	9.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—KRAS—pancreatitis	1.05e-05	9.84e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GCG—pancreatitis	1.05e-05	9.82e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PDGFA—pancreatitis	1.04e-05	9.76e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.03e-05	9.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—MDM2—pancreatitis	1.03e-05	9.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL18—pancreatitis	1.02e-05	9.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HGF—pancreatitis	1.02e-05	9.57e-05	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ALB—pancreatitis	1.01e-05	9.51e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GCG—pancreatitis	1.01e-05	9.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTHLH—pancreatitis	1.01e-05	9.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SMO—pancreatitis	1.01e-05	9.5e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—MDM2—pancreatitis	1.01e-05	9.47e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—XDH—pancreatitis	1e-05	9.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGB—pancreatitis	9.91e-06	9.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HTR2A—pancreatitis	9.89e-06	9.27e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PLA2G1B—pancreatitis	9.87e-06	9.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—HRAS—pancreatitis	9.86e-06	9.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—MDM2—pancreatitis	9.84e-06	9.23e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—LPL—pancreatitis	9.82e-06	9.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PPP3CA—pancreatitis	9.66e-06	9.06e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CTRB2—pancreatitis	9.57e-06	8.97e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—A2M—pancreatitis	9.53e-06	8.93e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—HRAS—pancreatitis	9.51e-06	8.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—pancreatitis	9.44e-06	8.85e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADH1B—pancreatitis	9.33e-06	8.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SST—pancreatitis	9.26e-06	8.69e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—LPL—pancreatitis	9.25e-06	8.67e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GCG—pancreatitis	9.22e-06	8.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DUSP6—pancreatitis	9.18e-06	8.61e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GCG—pancreatitis	9.14e-06	8.57e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—pancreatitis	9.11e-06	8.54e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—pancreatitis	9.06e-06	8.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—HRAS—pancreatitis	8.93e-06	8.37e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	8.73e-06	8.19e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALDH2—pancreatitis	8.72e-06	8.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BDKRB2—pancreatitis	8.71e-06	8.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—NRAS—pancreatitis	8.71e-06	8.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—CRP—pancreatitis	8.58e-06	8.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CNR1—pancreatitis	8.55e-06	8.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—pancreatitis	8.54e-06	8.01e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PPARG—pancreatitis	8.49e-06	7.96e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—INS—pancreatitis	8.33e-06	7.81e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FDX1—pancreatitis	8.3e-06	7.78e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—GCG—pancreatitis	8.26e-06	7.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—TLR4—pancreatitis	8.23e-06	7.72e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—LPL—pancreatitis	8.22e-06	7.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HLA-DRB1—pancreatitis	8.22e-06	7.71e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	8.15e-06	7.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—pancreatitis	8.09e-06	7.58e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	8.09e-06	7.58e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—LPL—pancreatitis	7.95e-06	7.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KNG1—pancreatitis	7.92e-06	7.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ICAM1—pancreatitis	7.89e-06	7.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CCL2—pancreatitis	7.73e-06	7.24e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADH4—pancreatitis	7.71e-06	7.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—NRAS—pancreatitis	7.69e-06	7.21e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ALB—pancreatitis	7.63e-06	7.16e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—NRAS—pancreatitis	7.58e-06	7.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—pancreatitis	7.55e-06	7.08e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—KRAS—pancreatitis	7.49e-06	7.03e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PLA2G1B—pancreatitis	7.45e-06	6.98e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—NRAS—pancreatitis	7.38e-06	6.92e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PDGFA—pancreatitis	7.29e-06	6.83e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PRSS1—pancreatitis	7.25e-06	6.8e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—LPL—pancreatitis	7.23e-06	6.78e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—A2M—pancreatitis	7.19e-06	6.74e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—LPL—pancreatitis	7.17e-06	6.72e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—INS—pancreatitis	7.03e-06	6.59e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PRSS3—pancreatitis	6.88e-06	6.45e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PNLIP—pancreatitis	6.88e-06	6.45e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—PTGS2—pancreatitis	6.68e-06	6.26e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL5—pancreatitis	6.63e-06	6.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—INS—pancreatitis	6.63e-06	6.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—KRAS—pancreatitis	6.62e-06	6.2e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GCG—pancreatitis	6.61e-06	6.19e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALDH2—pancreatitis	6.58e-06	6.17e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—KRAS—pancreatitis	6.52e-06	6.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LPL—pancreatitis	6.48e-06	6.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—HRAS—pancreatitis	6.37e-06	5.97e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—KRAS—pancreatitis	6.35e-06	5.96e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—XDH—pancreatitis	6.17e-06	5.78e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPP1—pancreatitis	6.14e-06	5.75e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CXCL8—pancreatitis	6.11e-06	5.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—pancreatitis	6.1e-06	5.72e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PPARG—pancreatitis	6e-06	5.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—MDM2—pancreatitis	5.97e-06	5.6e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—INS—pancreatitis	5.89e-06	5.52e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MDM2—pancreatitis	5.85e-06	5.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HTR2A—pancreatitis	5.84e-06	5.48e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PPARG—pancreatitis	5.81e-06	5.44e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADH1B—pancreatitis	5.75e-06	5.39e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—INS—pancreatitis	5.69e-06	5.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PTGS2—pancreatitis	5.64e-06	5.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—HRAS—pancreatitis	5.63e-06	5.27e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—HRAS—pancreatitis	5.54e-06	5.2e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MDM2—pancreatitis	5.51e-06	5.17e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	5.48e-06	5.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LEP—pancreatitis	5.43e-06	5.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—HRAS—pancreatitis	5.4e-06	5.06e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ALB—pancreatitis	5.4e-06	5.06e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—pancreatitis	5.38e-06	5.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—pancreatitis	5.36e-06	5.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PTGS2—pancreatitis	5.31e-06	4.98e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—pancreatitis	5.3e-06	4.97e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PPARG—pancreatitis	5.28e-06	4.95e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PPARG—pancreatitis	5.24e-06	4.91e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ALB—pancreatitis	5.22e-06	4.89e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—LPL—pancreatitis	5.18e-06	4.86e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—INS—pancreatitis	5.18e-06	4.86e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—INS—pancreatitis	5.13e-06	4.81e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GCG—pancreatitis	4.98e-06	4.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—NRAS—pancreatitis	4.9e-06	4.6e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ALB—pancreatitis	4.75e-06	4.45e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PTGS2—pancreatitis	4.72e-06	4.43e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ALB—pancreatitis	4.71e-06	4.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—INS—pancreatitis	4.64e-06	4.35e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PLA2G1B—pancreatitis	4.59e-06	4.3e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PTGS2—pancreatitis	4.57e-06	4.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CCL2—pancreatitis	4.57e-06	4.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—NRAS—pancreatitis	4.48e-06	4.2e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—A2M—pancreatitis	4.43e-06	4.15e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—NRAS—pancreatitis	4.39e-06	4.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—KRAS—pancreatitis	4.22e-06	3.96e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PTGS2—pancreatitis	4.15e-06	3.9e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—NRAS—pancreatitis	4.13e-06	3.88e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PTGS2—pancreatitis	4.12e-06	3.86e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—pancreatitis	4.08e-06	3.82e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALDH2—pancreatitis	4.05e-06	3.8e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—LPL—pancreatitis	3.91e-06	3.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MDM2—pancreatitis	3.86e-06	3.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KRAS—pancreatitis	3.85e-06	3.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—pancreatitis	3.84e-06	3.6e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PPARG—pancreatitis	3.78e-06	3.55e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KRAS—pancreatitis	3.78e-06	3.54e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—INS—pancreatitis	3.71e-06	3.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CXCL8—pancreatitis	3.61e-06	3.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—HRAS—pancreatitis	3.59e-06	3.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KRAS—pancreatitis	3.56e-06	3.34e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CASP3—pancreatitis	3.45e-06	3.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—pancreatitis	3.43e-06	3.22e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ALB—pancreatitis	3.4e-06	3.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—HRAS—pancreatitis	3.28e-06	3.07e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—HRAS—pancreatitis	3.21e-06	3.01e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—pancreatitis	3.14e-06	2.94e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—pancreatitis	3.07e-06	2.88e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GCG—pancreatitis	3.07e-06	2.88e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—HRAS—pancreatitis	3.02e-06	2.84e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PTGS2—pancreatitis	2.98e-06	2.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NRAS—pancreatitis	2.9e-06	2.71e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—pancreatitis	2.9e-06	2.71e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PPARG—pancreatitis	2.86e-06	2.68e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—INS—pancreatitis	2.8e-06	2.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—pancreatitis	2.69e-06	2.52e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ALB—pancreatitis	2.57e-06	2.41e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KRAS—pancreatitis	2.49e-06	2.34e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—LPL—pancreatitis	2.41e-06	2.26e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PTGS2—pancreatitis	2.25e-06	2.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—HRAS—pancreatitis	2.12e-06	1.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—pancreatitis	2.03e-06	1.9e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PPARG—pancreatitis	1.76e-06	1.65e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—INS—pancreatitis	1.73e-06	1.62e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ALB—pancreatitis	1.58e-06	1.48e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PTGS2—pancreatitis	1.38e-06	1.3e-05	CbGpPWpGaD
